Ex-GSK Lawyer's Acquittal Unlikely To Deter DoJ's Prosecution Of Execs
This article was originally published in The Tan Sheet
Executive Summary
A judge's decision to acquit former GlaxoSmithKline attorney Lauren Stevens of obstructing an FDA investigation and making false statements likely will not discourage the Department of Justice from prosecuting individual executives for health care fraud.
You may also be interested in...
Former KV Pharmaceutical CEO Sentenced To 30 Days In Jail
Marc Hermelin pleads guilty to distributing oversized morphine sulfate tablets; he may be first pharma exec to be jailed for healthcare fraud.
DoJ Case Against GSK Lawyer Flags What Individual Behavior Government May Target
Department of Justice charges former associate general counsel with obstruction and making false statements to FDA; indictment alleges she signed letters to FDA denying off-label promotion and withheld physician slides.
FTC Commissioner Recusal Decisions Should Be Public, US Chamber Of Commerce Says
Chamber files petition to have FTC amend its disqualification rules to have commissioners explain their rejection of recusal requests. FTC is seeking public comments on the petition.